Here are 1-3 brief analogies for Teladoc Health:

• Amazon for healthcare

• Uber for doctor visits

• Primary and Specialty Care Telehealth Solutions: Provides virtual consultations with doctors for general health concerns and specialized medical conditions.
• Chronic Condition Management: Offers digital programs and support for individuals managing chronic illnesses such as diabetes, hypertension, and heart failure.
• Expert Medical Services: Connects members with top medical experts for second opinions, complex diagnoses, and treatment plan guidance.
• Mental Health Solutions: Delivers virtual therapy, psychiatry, and mental wellness programs to address a range of behavioral health needs.
• Platform and Program Services: Provides the underlying technology platform and comprehensive program management for clients to offer virtual care to their members.

Teladoc Health (TDOC) serves a diverse range of major customers, primarily other companies, as well as individual members. Based on the provided background information, its major customer segments include:

• Employers
• Health plans
• Hospitals and health systems
• Insurance and financial services companies
• Individual members

The background information describes categories of customers rather than listing specific company names or their stock symbols.

Major Suppliers:

• Amazon (AMZN)

Chuck Divita, III Chief Executive Officer

Chuck Divita, III was appointed CEO of Teladoc Health in June 2024. Prior to this, he held senior leadership positions at GuideWell, a large health solutions organization that includes Florida Blue, where he served as Executive Vice President for Commercial Markets and Chief Financial Officer. Before joining GuideWell, Mr. Divita was the Chief Financial Officer of FPIC Insurance Group, a publicly traded property and casualty insurer. He has a reputation as an innovative, results-driven leader in the healthcare industry, recognized for driving growth and advancing new healthcare models. He has also served on the boards of various healthcare companies, including Prime Therapeutics, Availity, and VIM.

Mala Murthy Chief Financial Officer

Mala Murthy has served as the CFO of Teladoc Health since June 2019. She also served as acting Chief Executive Officer from April to June 2024. Before joining Teladoc Health, Ms. Murthy held several senior executive positions at American Express, including Chief Financial Officer of the Global Commercial Services segment. Prior to American Express, she held various leadership positions with PepsiCo, where she notably led high-growth business units and oversaw financial planning and analysis, corporate and international treasury, and corporate strategy. She has a proven track record of supporting multi-billion-dollar acquisitions and developing capital structure and liquidity strategies.

Dr. Vidya Raman-Tangella Chief Medical Officer

Dr. Vidya Raman-Tangella was named Chief Medical Officer of Teladoc Health in April 2022. In this role, she leads the company's enterprise clinical strategy, quality, and research efforts, with a focus on areas such as health equity and clinical evidence. Before joining Teladoc Health, Dr. Raman-Tangella was the general manager of Healthcare and Life Sciences Solutions at AWS (Amazon Web Services), where she developed strategies and solutions for the healthcare ecosystem. Her career includes leadership roles at prominent healthcare companies such as Blue Cross Blue Shield, Johnson & Johnson, and UnitedHealthcare, where she focused on designing integrated health and wellness solutions for employers and health plans. Her expertise lies in leveraging science, data, technology, and partnerships to create healthcare solutions for disease prevention, personalized patient experiences, and healthcare access.

Carlos Nueno President, International

Carlos Nueno is the President of International operations for Teladoc Health, a role he has held since July 2018. He is responsible for the strategic direction, operations, and client management of Teladoc Health's global footprint. Mr. Nueno co-founded and served as CEO of Advance Medical from 1999 to 2018, leading its growth to become a global provider of health services with over 900 employees across North America, Europe, and Asia. Advance Medical was acquired by Teladoc Health in 2018. Earlier in his career, he worked as a consultant for Gemini Consulting.

Kelly Bliss President, U.S. Group Health

Kelly Bliss is the President of Teladoc Health's U.S. Group Health business. She is responsible for overseeing strategy, partnerships, product management, marketing, sales, operations, and client management for virtual care services that reach over 100 million covered Americans. Prior to this role, Ms. Bliss served as Teladoc's Chief Client Officer from 2017 to 2020, where she was instrumental in achieving record client satisfaction and retention through a focus on delivering value and a best-in-class experience. She also played a key role in the integration efforts of several acquisitions, including the integration of Best Doctors after its acquisition by Teladoc Health in 2017, where she had previously served as Chief of Staff. Additionally, she contributed to integrating Livongo's chronic care management solutions after its acquisition by Teladoc Health. Ms. Bliss has built and managed high-performing global teams at companies such as Best Doctors and InterSystems.

The key risks to Teladoc Health (TDOC) primarily revolve around intense market competition, ongoing struggles with its BetterHelp segment impacting overall profitability, and the lasting repercussions of its significant acquisitions.

1. Intense Competition and Profitability Challenges: Teladoc Health operates in a highly competitive virtual healthcare market, facing pressure from traditional healthcare providers, new telehealth entrants, and large technology and retail companies expanding into healthcare. This environment leads to pricing pressure and difficulties in attracting and retaining users. A significant contributor to Teladoc's overall profitability struggles is its BetterHelp segment, which has experienced declining revenue and user numbers due to high customer acquisition costs. This segment's underperformance acts as a drag on the company's growth trajectory and its path to consistent profitability, with analysts not forecasting a full year of profitability until 2025 or later. The company has also recorded recurring goodwill impairment charges, reflecting past acquisitions not living up to their valuations.
2. Integration and Performance of Acquisitions: A major strategic move, the acquisition of Livongo in 2020, has been cited as a source of significant challenges. Issues included a high acquisition cost, difficulties in integrating the different company cultures and operating models, and a failure to quickly achieve expected synergies. These problems have contributed to substantial goodwill impairment charges and negative investor sentiment. While the company has worked to address these integration issues and a securities lawsuit related to the Livongo integration was dismissed, the ongoing struggles of the BetterHelp segment, which stemmed from this acquisition, continue to pose a risk to Teladoc's financial performance.
3. Regulatory and Reimbursement Uncertainty: As a provider of virtual healthcare services, Teladoc Health is highly susceptible to changes in healthcare laws, regulations, and reimbursement policies. The regulatory landscape for telehealth is dynamic, and shifts in government or private insurer reimbursement models could significantly impact the accessibility, demand, and profitability of Teladoc's services. The longevity of temporary regulatory changes that expanded telehealth access during the COVID-19 pandemic remains uncertain, requiring Teladoc to adapt to potential reversions that could affect service offerings and revenue.

1. Amazon's expansion into virtual primary care and chronic condition management: With initiatives like Amazon Clinic and the acquisition of One Medical, Amazon is a well-resourced, consumer-centric player directly entering Teladoc's core virtual care markets. Amazon's ability to bundle services, leverage its vast customer base, and utilize its logistics infrastructure poses a significant competitive threat, potentially disrupting established pricing models and customer acquisition strategies.

2. Vertical integration by major health plans and health systems: Large health plans (e.g., UnitedHealth Group's Optum, Cigna's Evernorth with MDLive, CVS Health/Aetna) are increasingly building out their own comprehensive virtual care platforms and directly acquiring or employing providers. Similarly, major health systems are enhancing their in-house telehealth capabilities, often integrating them deeply with their existing services. This trend could reduce their reliance on third-party virtual care providers like Teladoc, leading to increased competition for Teladoc's client base of employers and health plans, and potentially disintermediating Teladoc from parts of the care delivery chain.

Teladoc Health (symbol: TDOC) operates within several substantial addressable markets for its virtual healthcare services and solutions.

Virtual Healthcare Services (Telehealth/Telemedicine)

• The global telehealth market was estimated at approximately USD 123.26 billion in 2024 and is projected to reach USD 455.27 billion by 2030, growing at a CAGR of 24.68% from 2025 to 2030.
• Another estimate places the global telehealth market size at USD 126.1 billion in 2024, anticipated to grow to USD 403.2 billion by 2034, at a CAGR of 12.4% from 2025 to 2034.
• The U.S. telehealth market generated a revenue of USD 42,540.9 million in 2024 and is expected to reach USD 150,131.3 million by 2030, with a CAGR of 23.8% from 2025 to 2030.
• The U.S. virtual care market was estimated at USD 8.83 billion in 2024 and is expected to grow at a CAGR of 32.35% from 2025 to 2030. Another projection for the U.S. virtual care market indicates a value of USD 12.48 billion in 2025, reaching USD 206.74 billion by 2035 at a CAGR of 32.39% from 2026 to 2035.
• Teladoc Health has stated its combined total addressable market in the telehealth space is approximately USD 121 billion.

Chronic Condition Management

• The global chronic disease management market was valued at USD 8.33 billion in 2024 and is expected to reach USD 27.90 billion by 2032, with a CAGR of 16.30% from 2025 to 2032.
• Another report values the global chronic disease management market at USD 5.82 billion in 2024, projected to increase to USD 20.87 billion by 2034, expanding at a CAGR of 13.62% from 2025 to 2034.
• The U.S. chronic disease management market size was USD 1.75 billion in 2024 and is projected to be worth around USD 6.38 billion by 2034, growing at a CAGR of 13.80% from 2025 to 2034.

Mental Health Solutions

• The global mental health market size is forecast to increase by USD 153.3 billion at a CAGR of 6.8% between 2024 and 2029.
• The mental health apps market globally is projected to reach USD 22.73 billion by 2030, from USD 9.94 billion in 2025, at a CAGR of 18.0% during the forecast period.
• North America is estimated to contribute 36% to the growth of the global mental health market during the forecast period.

Teladoc Health (TDOC) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market shifts:

1. Transition to Visit-Oriented Models and Growth in Integrated Care: Teladoc Health is strategically shifting its U.S. virtual care subscriptions from traditional subscription-based models to more visit-oriented models, which are more reflective of the U.S. healthcare fee-for-service construct. While this shift may initially impact subscription revenue, the company anticipates that growth in visit volumes will become a key driver of overall revenue in the long term. The Integrated Care segment, which serves health plans, employers, and health systems, is projected to see revenue growth between 0.4% and 3.9% in 2026, with contributions from recent acquisitions.
2. Scaling BetterHelp's Insurance Offering: The BetterHelp segment, Teladoc Health's virtual mental health platform, is undergoing a significant transition from a cash-pay model to an in-network, insurance-covered model. This expansion into accepting insurance is identified as a major growth opportunity, with Teladoc Health forecasting BetterHelp's insurance revenue to range from $75 million to $90 million in 2026, with an annualized revenue run rate exceeding $100 million.
3. International Market Expansion: Teladoc Health is actively pursuing growth in international markets, with expectations for double-digit revenue growth from its international segment in 2026. The company is expanding its presence and establishing partnerships in new regions, including France, Germany, the Netherlands, Spain, and Austria.
4. New Innovations and AI Advancements in Integrated Care: The company is investing in new innovations and capabilities within its Integrated Care products, particularly through advancements in artificial intelligence. The Pulse platform, for instance, is designed to unify extensive data, apply intelligence, and connect AI-driven insights to patient care, thereby enhancing virtual care offerings and supporting future growth.

Share Repurchases

• Teladoc Health reported no share repurchases for the trailing twelve months ended September 2025, and $0 million for the three months ended September 2025.

Share Issuance

• On May 22, 2025, Teladoc Health’s stockholders approved an amendment to the 2023 Incentive Award Plan, increasing the number of shares available for issuance by 6.85 million.
• In Q4 2025, Teladoc Health had 178 million shares outstanding, representing a 0.5% increase from the prior quarter.
• The company announced an employee inducement award under NYSE Rule 303A.08 on March 4, 2026, for a new employee.

Outbound Investments

• In April 2025, Teladoc Health acquired digital mental health company UpLift for $45 million, consisting of $30 million cash and up to $15 million in contingent earnouts, to expand its virtual mental health services.
• In February 2025, Teladoc Health signed an agreement to acquire virtual preventive care company Catapult Health for $65 million, with an additional $5 million in contingent earnout consideration, aiming to enhance chronic condition management and at-home diagnostic testing.
• Teladoc Health acquired Telecare, a provider of teleconsultation services, in August 2025.

Capital Expenditures

• Capital expenditures and capitalized software development costs totaled $127.5 million for the full year 2025, an increase from $124.1 million in 2024.
• For the first nine months of 2025, capital expenditures and capitalized software development costs were $93.1 million, compared to $94.4 million in the first nine months of 2024.
• The capital expenditures are focused on necessary investments in the company's platform and technology, product innovation, enhanced cardiometabolic programs, integrated mental health offerings, and international expansion.